Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials

Clinical Governance: An International Journal

ISSN: 1477-7274

Article publication date: 16 October 2009

51

Citation

(2009), "Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials", Clinical Governance: An International Journal, Vol. 14 No. 4. https://doi.org/10.1108/cgij.2009.24814dae.003

Publisher

:

Emerald Group Publishing Limited

Copyright © 2009, Emerald Group Publishing Limited


Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials

Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 14, Issue 4

J.S. Berger, M.J. Krantz, J.M. Kittelson and W.R. Hiatt,JAMA,2009,Vol. 301,pp. 1909-1919,

This review found that aspirin treatment in patients with peripheral artery disease provided a statistically significant reduction in nonfatal stroke but not in cardiovascular events. The authors also concluded that given the limited statistical power of their analysis, further randomised controlled trials are required. These cautious conclusions are likely to be reliable.

Related articles